Definitive Healthcare Corp
For the period ended Mar 31, 2025. Filed May 8, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 8, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities and Use of Proceeds
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Pursuant to the terms of the Amended LLC Agreement, holders of LLC Units have the right to exchange all or a portion of their LLC Units for newly issued shares of Class A Common Stock on a one-for-one basis, which issuances are made in reliance on Section 4(a)(2) of the Securities Act. Upon any such exchange, a corresponding number of shares of Class B Common Stock held by such LLC Unit holders are cancelled. Such exchanges executed in the three months ended March 31, 2025 are as follows:
| Date of Exchange | Number of Shares Exchanged |
|---|---|
| January 6, 2025 | 346,981 |
| February 10, 2025 | 15,000 |
| February 17, 2025 | 79,462 |
| Total | 441,443 |
The following table sets forth certain information with respect to repurchases of our Class A Common Stock during the quarter ended March 31, 2025.
| ISSUER PURCHASES OF EQUITY SECURITIES | ||||
|---|---|---|---|---|
| Period | Total Number of Shares Purchased | Average Price Paid Per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (1) | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (1)(in thousands) |
| January 1 - January 31, 2025 | 940,134 | $4.58 | 940,134 | $93,424 |
| February 1 - February 28, 2025 | 1,700,622 | $4.94 | 1,700,622 | $85,018 |
| March 1 - March 31, 2025 | 2,963,995 | $2.81 | 2,963,995 | $76,686 |
| Total | 5,604,751 | $3.75 | 5,604,751 | |
(1)
On November 1, 2024, our board of directors announced a stock repurchase program (the “2025 Repurchase Program”) of our Class A Common Stock authorizing up to $100.0 million in share repurchases. The Repurchase Program expires on December 31, 2025. Repurchases may be effected, from time to time, either on the open market (including pre-set trading plans), in privately negotiated transactions, and other transactions in accordance with applicable securities laws.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.